Cholesterol embolization syndrome induced by thrombolytic therapy

American Journal of Cardiovascular Drugs

Volumn 8, Issue 1, 2008, Pages 27-34

  Hitti, Wassim A ^a,b   Wali, Ravinder K ^a   Weinman, Edward J ^a   Drachenberg, Cinthia ^a   Briglia, Andrew ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cardiovascular disorders; Cholesterol embolisation syndrome, drug induced; Thrombolytics, adverse reactions

Indexed keywords

ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CREATININE; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILOPROST; STATINE DERIVATIVE; STREPTOKINASE; WARFARIN;

ABDOMINAL PAIN; ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; AMPUTATION; BACKACHE; BIOPSY; BLOOD CLOT LYSIS; CENTRAL NERVOUS SYSTEM DISEASE; CHOLESTEROL EMBOLISM; CHOLESTEROL EMBOLIZATION SYNDROME; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CYANOSIS; DEATH; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM PERFORATION; DISEASE COURSE; DRUG INDICATION; DRUG MEGADOSE; DUODENUM ULCER; EOSINOPHILIA; FEVER; GANGRENE; GASTROINTESTINAL HEMORRHAGE; HEMATOCHEZIA; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; INTESTINE INFARCTION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVEDO RETICULARIS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; MYALGIA; PENILE NECROSIS; PEPTIC ULCER BLEEDING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RARE DISEASE; RASH; RECTUM HEMORRHAGE; RECURRENCE RISK; RETINA BLOOD VESSEL OCCLUSION; REVIEW; SIDE EFFECT; SKIN DISEASE; SKIN MANIFESTATION; SKIN NECROSIS; SKIN ULCER; STOMACH ULCER; TARGET ORGAN; AGED; CHEMICALLY INDUCED; EMBOLISM, CHOLESTEROL; FEMALE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; SYNDROME; VENOUS THROMBOSIS;

AGED; EMBOLISM, CHOLESTEROL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SYNDROME; VENOUS THROMBOSIS;

EID: 39749198166     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200808010-00004     Document Type: Review

References (65)

1. Ramirez G, O'Neill Jr WM, Lamberts R, et al. Cholesterol embolization: a complication of angiography. Arch Intern Med 1978; 138 (9): 1430-2
2. Suzuki Y, Kato J, Kyoraku Y, et al. Cholesterol embolism in a patient with inflammatory abdominal aortic aneurysm. Intern Med 1999; 38 (11): 861-4
3. Nakamura S, Misumi I, Koide S. Cholesterol embolism as a complication of aortic dissection. Circulation 1999; 100: e48-50
4. Hyman BT, Landas SK, Ashman RF, et al. Warfarin-related purple toe syndrome and cholesterol microembolization. Am J Med 1987; 82 (6): 1233-7
5. Glassock RJ, Ritz E, Bommer J, et al. Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol 1984; 4 (3): 193-200
6. Scolari F, Bracchi M, Valzorio B, et al. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant 1996; 11 (8): 1607-12
7. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs heparin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339 (8796): 753-70
8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329 (10): 673-82
9. Califf RM, Fortin DF, Tenaglia AN, et al. Clinical risks of thrombolytic therapy. Am J Cardio 1992; 69 (2): 12A-20A
10. Schwartz MW, McDonald GB. Cholesterol embolization syndrome: occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA 1987; 258 (14): 1934-5
11. Pirson Y, Honhon B, Cosyns JP, et al. Cholesterol embolism in a renal graft after treatment with streptokinase. BMJ 1988; 296 (6619): 394-5
12. Blankenship J. Multiple cholesterol embolization after intravenous thrombolytic therapy and cardiac catheterization for acute myocardial infarction. J Invasive Cardiol 1989; 1 (3): 175-9
13. Ridker PM, Michel T. Streptokinase therapy and cholesterol embolization. Am Med 1989; 87 (3): 357-8
14. Shapiro LS. Cholesterol embolization after treatment with tissue plasminogen activator [letter]. N Engl J Med 1989; 321 (18): 1270
15. Hendel RC, Cuenoud HF, Giansiracussa DF, et al. Multiple cholesterol emboli syndrome. Arch Int Med 1898; 149 (10): 2371-4
16. Bhardwaj M, Goldweit R, Erlebacher J, et al. Tissue plasminogen activator and cholesterol crystal embolization. Ann Int Med 1989; 111 (8): 687-8
17. Kawakami Y, Hirose K, Watanabe Y, et al. Management of multiple cholesterol embolization syndrome: a case report. Angiology 1990; 41 (3): 248-52
18. Queen M, Biem HJ, Moe G. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction. Am J Cardiol 1990; 65 (15): 1042-3
19. Beutler JJ, Sulzer MA, van Stralen R. Cholesterol embolism after intravenous anisoylated plasminogen streptokinase activator complex (APSAC). Neth Med 1991; 39 (5-6): 373-4
20. Pochmalicki G, Feldman L, Meunier P, et al. Cholesterol embolisation syndrome after thrombolytic therapy for myocardial infarction. Lancet 1992; 339 (8784): 58-9
21. Mendia R, Cavaliere G, Sparacio F, et al. Does thrombolysis produce cholesterol embolisation [letter]. Lancet 1992; 339 (8792): 562
22. King AJ, Carlson JA. Case 38: 1993 renal failure and a painful toe in a 70 year old man after an acute myocardial infarct. N Eng J Med 1993; 329: 948-55
23. Arora R, Magun A, Grossman M, et al. Cholesterol embolization syndrome after intravenous tissue plasminogen activator for acute myocardial infarction. Am Heart J 1993; 126 (1): 225-8
24. Gupta BK, Spinowitz BS, Charytan C, et al. Cholesterol crystal embolization associated renal failure after therapy with recombinant tissue-type plasminogen activator. Am J Kidney Dis 1993; 21 (6): 659-62
25. Turnbull RG, Hayashi AH, McLean R. Multiple spontaneous intestinal perforations from atheroemboli after thrombolytic therapy: a case report. Can J Surg 1994, 328
26. Ben-Chitrit S, Korzets Z, Hershkovitz R, et al. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator. Nephrol Dial Transplant 1994; 9 (4): 428-30
27. Blair NP, Hayes GW. Perforation of the small bowel: a case report. Can J Surg 1995; 38 (3): 281-2
28. Geraets DR, Hoehns JD, Burke TG, et al. Thrombolytic-associated cholesterol emboli syndrome: case report and literature review. Pharmacotherapy 1995; 15 (4): 421-50
29. Wong FK, Chan SW, Ing TS, et al. Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am J Kidney Dis 1995; 26 (3): 508-10
30. Mahfood P, Brown M. Renal failure after two myocardial infarctions. Hosp Pract 1996; 31 (8): 25-6
31. Adorati M, Pizzolitto S, Franzon R, et al. Cholesterol embolism and acute interstitial nephritis: two adverse effects of streptokinase thrombolytic therapy in the same patient. Nephrol Dial Transplant 1998; 13 (5): 1262-4
32. Rivera-Manrique E, Castro-Salomo A, Azon-Maslover A. Cholesterol embolism: a fatal complication after thrombolytic therapy for acute myocardial infarction [letter]. Arch Int Med 1998; 158 (14): 1575
33. Pettelot G, Bracco J, Barrillon D, et al. Cholesterol embolization: unrecognized complication of thrombolysis [letter]. Circulation 1998; 97 (15): 1522
34. Pennington M, Yeager J, Skelton H, et al. Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors. Br J Derm 2002; 146 (3): 511-7
35. Baldwin SH, Musa J. Cholesterol emboli syndrome occurring after administration of tissue plasminogen activator [letter]. J Miss State Med Assoc 2002; 43 (4): 108
36. Hitti WA, Anderson J. Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy. South Med J 2005; 98 (2): 235-7
37. Blankenship JC. Cholesterol embolisation after thrombolytic therapy. Drug Safety 1996; 14 (2): 78-84
38. Drost H, Buis B, Haan D, et al. Cholesterol embolism as a complication of left heart catheterization: report of seven cases. Br Heart J 1984; 52 (3): 339-42
39. Blankenship JC, Butler M, Garbes A. Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 1995; 107: 662-8
40. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987; 38 (10): 769-84
41. Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000; 36 (6): 1089-109
42. Jones DB, Iannacone PM. Athermotaous emboli in renal biopsies: an ultrastructural study. Am J Pathol 1975; 78: 261-76
43. Vidt DG. Cholesterol emboli: a common cause of renal failure. Annu Rev Med 1997; 48: 375-85
44. Haqqie SS, Urizar RE, Slingh J. Nephrotic-range proteinuria in renal atheroembolic renal disease: report of four cases. Am J Kidney Dis 1996; 28 (4): 493-501
45. Wilson DM, Salazer TL, Farkouh ME. Eosinophiluria in atheroembolic renal disease. Am J Med 1991; 91 (2): 186-9
46. Bourdages R, Prentice RS, Beck IT, et al. Atheromatous embolization to the stomach: an unusual cause of gastrointestinal bleeding. Am J Dig Dis 1976; 21 (10): 889-94
47. Moolenaar W, Lamers CB. Gastrointestinal blood loss due to cholesterol crystal embolization. J Clin Gastroenterol 1995; 21 (3): 220-3
48. Moolenaar W, Lamers C. Cholesterol crystal embolization to liver, gallbladder, and pancreas. Dig Dis Sci 1996; 41 (9): 1819-22
49. Bunt TJ. The clinical significance of the asymptomatic Hollenhorst plaque. J Vasc Surg 1986; 4 (6): 559-62
50. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42 (2): 211-6
51. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122 (10): 1194-8
52. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003; 14 (6): 1584-90
53. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999; 33 (5): 840-50
54. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery 1989; 105 (6): 737-46
55. Thadhani RI, Camargo CA, Xavier RJ, et al. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Medicine 1995; 74 (6): 350-8
56. Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 1998; 351 (9112): 1331-2
57. Cabili S, Hochman I, Goor Y. Reversal of gangrenous lesions in the blue toe syndrome with lovastatin: a case report. Angiology 1993; 44 (10): 821-5
58. Blanco-Colio LM, Tunon J, Martin-Ventura JL, et al. Antiinflammatory and immunomodulatory effects of statins. Kidney Int 2003; 63 (1): 12-23
59. Shabanzadeh AP, Shuaib A, Wang CX. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res 2005; 1042 (1): 1-5
60. Hasegawa M, Kawashima S, Shikano M, et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease: a report of 5 cases. Am J Nephrol 2000; 20 (4): 263-7
61. Rosanosky SJ. Multiple cholesterol emboli syndrome. South Med J 1982; 75: 677-80
62. Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. Br Med J 2002; 324 (7332): 268-9
63. Ghilardi G, Massaro F, Gobatti D, et al. Temporary spinal cord stimulation for peripheral cholesterol embolism. J Cardiovasc Surg 2002; 43 (2): 255-8
64. Keen RR, McCarthy WJ, Shireman PK, et al. Surgical management of atheroembolization. J Vasc Surg 1995; 21: 773-80
65. Friedman SG, Krishnasastry KV. External iliac ligation and axillary-bifemoral bypass for blue toe syndrome. Surgery 1994; 115: 27-30